Anavex Life Sciences
AVXL
#7563
Rank
$0.39 B
Marketcap
$4.40
Share price
-1.12%
Change (1 day)
-42.11%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $11.47 Million USD

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are $11.47 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30$15.3 M22.1%
2023-09-30$12.53 M22.71%
2022-09-30$10.21 M-5.41%
2021-09-30$10.79 M47.81%
2020-09-30$7.3 M44.96%
2019-09-30$5.03 M29.73%
2018-09-30$3.88 M8.38%
2017-09-30$3.58 M12.34%
2016-09-30$3.19 M19.9%
2015-09-30$2.66 M-62.84%
2014-09-30$7.16 M150.67%
2013-09-30$2.85 M-1.1%
2012-09-30$2.88 M114.67%
2011-09-30$1.34 M-59.11%
2010-09-30$3.29 M-22.89%
2009-09-30$4.26 M85.55%
2008-09-30$2.29 M397.13%
2007-09-30$0.46 M1551.54%
2006-09-30$0.02 M3.74%
2005-09-30$0.02 M977.72%
2004-09-30$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
$0.52 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.83 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
$0.19 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$10.11 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA